Migraine

Migraine Treatment With Needle-Free Delivery System No Longer Available

By February 27, 2018

Both strengths of Sumavel DosePro have now been discontinued.

BLA Submitted for Migraine Prevention Drug Fremanezumab

By October 17, 2017

The studies looked at the safety, tolerability, and efficacy of 4 dose regimens of subcutaneous fremanezumab vs. placebo over 16 weeks.